Cyxtera Announces Third Quarter 2022 Results
Cyxtera (NASDAQ: CYXT) announced strong third-quarter results for 2022, reporting total revenue of $186.6 million, up by 5.4% compared to the previous year. Recurring revenue rose 5.2% to $178.1 million, while core revenue increased by 7.3% to $172.8 million. The company achieved its 11th consecutive quarter of positive net bookings. Despite a net loss of $55.9 million, Transaction Adjusted EBITDA grew by 0.8% to $58.5 million. Cyxtera also revealed plans to convert to a Real Estate Investment Trust and affirmed its full-year revenue guidance of $730 to $760 million.
- Total revenue increased by $9.5 million (5.4%) to $186.6 million.
- Recurring revenue rose by $8.8 million (5.2%) to $178.1 million.
- Core revenue increased by $11.8 million (7.3%) to $172.8 million.
- Annualized core bookings grew by 20% sequentially.
- Stabilized occupancy improved by 480 basis points YoY to 73.7%.
- Net financial leverage declined to 3.6x.
- Closed $37.5 million receivable securitization facility, reducing interest expense.
- Net loss of $55.9 million in Q3 2022.
“We are pleased to report strong performance in the third quarter, including our 11th consecutive quarter of positive net bookings,” said
Q3 2022 Financial Highlights
-
Total revenue increased by
, or$9.5 million 5.4% year over year, to .$186.6 million -
On a constant currency basis, total revenue increased by
, or$14.1 million 8.0% year over year. -
Recurring revenue increased by
, or$8.8 million 5.2% year over year, to .$178.1 million -
Core revenue increased by
, or$11.8 million 7.3% year over year, to .$172.8 million -
Net Loss of
in the quarter; Transaction Adjusted EBITDA[1] increased by$55.9 million , or$0.4 million 0.8% year over year, to and increased by$58.5 million , or$2.8 million 4.9% year over year, on a constant currency basis.
1 A complete reconciliation of Net Loss to Transaction Adjusted EBITDA is included in the financial tables included in this release.
Q3 2022 Business Highlights
-
Annualized Core bookings increased
20% sequentially. -
Average monthly Core churn of
0.8% in the third quarter. -
Stabilized occupancy increased 480 basis points year over year to
73.7% . - Net financial leverage declined 10 basis points and 20 basis points year over year and sequentially, respectively, to 3.6x.
-
Closed an accounts receivable securitization facility of
with$37.5 million PNC Bank, N.A. , providing increased availability and reduced interest expense. - Announced the intention to convert to a Real Estate Investment Trust (REIT).
“Cyxtera’s team once again delivered solid financial results in the third quarter, as we move through the second half of the year,” said
2022 Outlook
2022 Guidance |
|||
($ in millions) |
|
|
|
|
2022E |
2021A |
Y/Y % Change |
Revenue |
|
|
|
Transaction Adjusted EBITDA |
|
|
|
Maintenance Capital Expenditures |
|
|
|
% of Revenue |
|
|
60 bps - 70 bps |
Expansion Capital Expenditures |
|
|
|
Q3 2022 Results Conference Call and Replay Information
The
Investor Presentation and Supplemental Financial Information
Concurrently with holding its conference call,
Upcoming Conferences and Events
- Nareit REITworld 2022 Annual Conference
-
Raymond James 2022Technology Investors Conference -
UBS 50th annualGlobal TMT Conference
About
Forward-Looking Statements
This press release includes “forward-looking statements” within the meaning of the federal securities laws. Forward- looking statements contained in this press release include statements concerning Cyxtera’s estimated financial performance for 2022 and its plans to convert to a REIT. Because forward-looking statements are predictions, projections and other statements about future events that are based on current expectations and assumptions, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of Cyxtera’s control. Actual results and conditions (financial or otherwise) may differ materially from those indicated in the forward-looking statements. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results and conditions to differ materially from those indicated in the forward-looking statements, including, but not limited to, the effects of the COVID-19 pandemic on Cyxtera’s business or future results, including supply chain disruptions; Cyxtera’s ability to maintain its credit ratings; Cyxtera’s ability to access external sources of capital on favorable terms or at all, which could limit Cyxtera’s ability to execute its business and growth strategies; increases in interest rates; fluctuations in energy prices; fluctuations in foreign currency exchange rates in the markets in which
Statement Regarding Non-GAAP Financial Measures
This press release contains Transaction Adjusted EBITDA, which is a supplemental measure that is not required by, or presented in accordance with, accounting principles generally accepted in
This press release also includes certain projections of non-GAAP financial measures concerning
This press release includes constant currency revenue, MRR and Transaction Adjusted EBITDA, which are non-GAAP financial measures and are not meant to be considered in isolation or as an alternative to GAAP revenue and GAAP net income (loss).
Consolidated Balance Sheets (unaudited, in millions, except share information) |
|||||||
|
|
|
|
||||
Assets: |
|
|
|
||||
Current assets: |
|
|
|
||||
Cash |
$ |
86.2 |
|
|
$ |
52.4 |
|
Accounts receivable, net of allowance of |
|
20.2 |
|
|
|
18.3 |
|
Prepaid and other current assets |
|
37.0 |
|
|
|
37.5 |
|
Total current assets |
|
143.4 |
|
|
|
108.2 |
|
|
|
|
|
||||
Property and equipment, net |
|
1,636.1 |
|
|
|
1,530.8 |
|
Operating lease right-of-use assets |
|
248.3 |
|
|
|
— |
|
|
|
748.5 |
|
|
|
761.7 |
|
Intangible assets, net |
|
441.8 |
|
|
|
519.8 |
|
Other assets |
|
18.7 |
|
|
|
16.7 |
|
Total assets |
$ |
3,236.8 |
|
|
$ |
2,937.2 |
|
|
|
|
|
||||
Liabilities and shareholders’ equity: |
|
|
|
||||
Current liabilities: |
|
|
|
||||
Accounts payable |
$ |
63.0 |
|
|
$ |
57.9 |
|
Accrued expenses |
|
74.9 |
|
|
|
65.3 |
|
Current portion of operating lease liabilities |
|
33.8 |
|
|
|
— |
|
Current portion of long-term debt, finance leases and other financing obligations |
|
52.6 |
|
|
|
50.3 |
|
Deferred revenue |
|
64.1 |
|
|
|
60.7 |
|
Other current liabilities |
|
22.3 |
|
|
|
10.0 |
|
Total current liabilities |
|
310.7 |
|
|
|
244.2 |
|
|
|
|
|
||||
Operating leases liabilities, net of current portion |
|
273.5 |
|
|
|
— |
|
Long-term debt, net of current portion |
|
897.0 |
|
|
|
896.5 |
|
Finance leases and other financing obligations, net of current portion |
|
1,075.1 |
|
|
|
937.8 |
|
Deferred income taxes |
|
31.0 |
|
|
|
29.9 |
|
Warrant liabilities |
|
— |
|
|
|
64.7 |
|
Other liabilities |
|
72.0 |
|
|
|
158.2 |
|
Total liabilities |
$ |
2,659.3 |
|
|
$ |
2,331.3 |
|
|
|
|
|
||||
Commitments and contingencies (Note 16) |
|
|
|
||||
|
|
|
|
||||
Shareholders’ equity: |
|
|
|
||||
Preferred Stock, |
|
— |
|
|
|
— |
|
Class A common stock, |
|
— |
|
|
|
— |
|
Additional paid-in capital |
|
1,961.7 |
|
|
|
1,816.5 |
|
Accumulated other comprehensive (loss) income |
|
(17.9 |
) |
|
|
10.8 |
|
Accumulated deficit |
|
(1,366.3 |
) |
|
|
(1,221.4 |
) |
Total shareholders’ equity |
|
577.5 |
|
|
|
605.9 |
|
Total liabilities and shareholders’ equity |
$ |
3,236.8 |
|
|
$ |
2,937.2 |
|
Consolidated Statements of Operations (unaudited, in millions, except for share information) |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2022 |
|
2021 |
|
2022 |
|
2021 |
||||||||
Revenues |
$ |
186.6 |
|
|
$ |
177.1 |
|
|
$ |
553.0 |
|
|
$ |
525.3 |
|
Operating costs and expenses |
|
|
|
|
|
|
|
||||||||
Cost of revenues, excluding depreciation and amortization |
|
100.3 |
|
|
|
93.5 |
|
|
|
296.7 |
|
|
|
287.4 |
|
Selling, general and administrative expenses |
|
37.9 |
|
|
|
29.2 |
|
|
|
103.8 |
|
|
|
79.7 |
|
Depreciation and amortization |
|
60.0 |
|
|
|
59.4 |
|
|
|
183.1 |
|
|
|
180.6 |
|
Restructuring, impairment, site closures and related costs |
|
1.3 |
|
|
|
1.4 |
|
|
|
3.9 |
|
|
|
68.4 |
|
Transaction-related costs |
|
— |
|
|
|
5.2 |
|
|
|
— |
|
|
|
5.2 |
|
Total operating costs and expenses |
|
199.5 |
|
|
|
188.7 |
|
|
|
587.5 |
|
|
|
621.3 |
|
|
|
|
|
|
|
|
|
||||||||
Loss from operations |
|
(12.9 |
) |
|
|
(11.6 |
) |
|
|
(34.5 |
) |
|
|
(96.0 |
) |
Interest expense, net |
|
(41.1 |
) |
|
|
(43.1 |
) |
|
|
(118.6 |
) |
|
|
(129.3 |
) |
Other expenses, net |
|
(2.4 |
) |
|
|
(0.4 |
) |
|
|
(2.0 |
) |
|
|
(1.2 |
) |
Change in fair value of warrant liabilities |
|
— |
|
|
|
(2.7 |
) |
|
|
11.8 |
|
|
|
(2.7 |
) |
Loss from operations before income taxes |
|
(56.4 |
) |
|
|
(57.8 |
) |
|
|
(143.3 |
) |
|
|
(229.2 |
) |
Income tax benefit (expense) |
|
0.5 |
|
|
|
11.1 |
|
|
|
(1.6 |
) |
|
|
36.9 |
|
Net loss |
$ |
(55.9 |
) |
|
$ |
(46.7 |
) |
|
$ |
(144.9 |
) |
|
$ |
(192.3 |
) |
|
|
|
|
|
|
|
|
||||||||
Loss Per Share |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
$ |
(0.31 |
) |
|
$ |
(0.32 |
) |
|
$ |
(0.82 |
) |
|
$ |
(1.58 |
) |
|
|
|
|
|
|
|
|
||||||||
Weighted average number of shares outstanding |
|
|
|
|
|
|
|
||||||||
Basic and diluted |
|
179,121,387 |
|
|
|
147,754,776 |
|
|
|
177,637,729 |
|
|
|
121,868,742 |
|
Consolidated Statements of Cash Flows (unaudited, in millions) |
|||||||
|
Nine Months Ended |
||||||
|
2022 |
|
2021 |
||||
Net loss |
$ |
(144.9 |
) |
|
$ |
(192.3 |
) |
Cash flows from operating activities: |
|
|
|
||||
Adjustments to reconcile net loss to net cash provided by operating activities: |
|
|
|
||||
Depreciation and amortization |
|
183.1 |
|
|
|
180.6 |
|
Restructuring, impairment, site closures and related costs |
|
— |
|
|
|
2.0 |
|
Amortization of favorable/unfavorable leasehold interests, net |
|
— |
|
|
|
2.9 |
|
Amortization of debt issuance costs and fees, net |
|
3.0 |
|
|
|
9.1 |
|
Equity-based compensation |
|
16.0 |
|
|
|
5.4 |
|
Reversal of allowance for doubtful accounts |
|
(0.4 |
) |
|
|
(1.1 |
) |
Deferred income taxes |
|
2.5 |
|
|
|
(37.1 |
) |
Change of fair value of warrant liabilities |
|
(11.8 |
) |
|
|
2.7 |
|
Non-cash interest expense, net |
|
8.3 |
|
|
|
7.1 |
|
Changes in operating assets and liabilities, excluding impact of acquisitions and dispositions: |
|
|
|
||||
Accounts receivable |
|
(1.5 |
) |
|
|
8.3 |
|
Prepaid and other current assets |
|
0.5 |
|
|
|
3.1 |
|
Other assets |
|
(2.4 |
) |
|
|
8.1 |
|
Operating lease right-of-use assets |
|
28.7 |
|
|
|
— |
|
Operating lease liabilities |
|
(32.3 |
) |
|
|
— |
|
Accounts payable |
|
1.1 |
|
|
|
(10.5 |
) |
Accrued expenses |
|
9.4 |
|
|
|
(27.7 |
) |
Due to affiliates |
|
— |
|
|
|
(22.8 |
) |
Other liabilities |
|
14.7 |
|
|
|
63.0 |
|
Net cash provided by operating activities |
|
74.0 |
|
|
|
0.8 |
|
Cash flows from investing activities: |
|
|
|
||||
Purchases of property and equipment |
|
(100.4 |
) |
|
|
(44.1 |
) |
Amounts received from affiliate (Note 18) |
|
— |
|
|
|
117.1 |
|
Net cash (used in) provided by investing activities |
|
(100.4 |
) |
|
|
73.0 |
|
Cash flows from financing activities: |
|
|
|
||||
Proceeds from issuance of long-term debt and other financing obligations |
|
42.0 |
|
|
|
40.0 |
|
Proceeds from recapitalization, net of issuance costs |
|
— |
|
|
|
436.0 |
|
Repayment of long-term debt |
|
(46.9 |
) |
|
|
(459.4 |
) |
Repayment of finance leases and other financing obligations |
|
(37.0 |
) |
|
|
(49.1 |
) |
Proceeds from sales leaseback financing |
|
26.7 |
|
|
|
— |
|
Capital redemption |
|
— |
|
|
|
(97.9 |
) |
Capital contribution |
|
— |
|
|
|
5.2 |
|
Proceeds from the exercise of warrants, net of redemptions |
|
1.3 |
|
|
|
— |
|
Proceeds from the exercise of the optional share purchase options |
|
75.0 |
|
|
|
— |
|
Net cash provided by (used in) financing activities |
|
61.1 |
|
|
|
(125.2 |
) |
Effect of foreign currency exchange rates on cash |
|
(0.9 |
) |
|
|
5.2 |
|
Net increase (decrease) in cash |
|
33.8 |
|
|
|
(46.2 |
) |
Cash at beginning of period |
|
52.4 |
|
|
|
120.7 |
|
Cash at end of period |
$ |
86.2 |
|
|
$ |
74.5 |
|
|
|
|
|
||||
Supplemental cash flow information: |
|
|
|
||||
Cash (refund) paid for income taxes, net |
$ |
(0.1 |
) |
|
$ |
4.3 |
|
Cash paid for interest |
$ |
21.9 |
|
|
$ |
67.6 |
|
Non-cash purchases of property and equipment |
$ |
4.1 |
|
|
$ |
19.4 |
|
RECONCILIATION OF GAAP TO NON-GAAP RESULTS (unaudited, in millions) |
|||||||
|
Three Months Ended
|
||||||
|
2022 |
|
2021 |
||||
Net Loss to EBITDA Reconciliation: |
|
|
|
||||
Net loss |
$ |
(55.9 |
) |
|
|
(46.7 |
) |
Depreciation and amortization |
|
60.0 |
|
|
|
59.4 |
|
Interest and other expenses, net |
|
43.5 |
|
|
|
43.5 |
|
Income tax benefit |
|
(0.5 |
) |
|
|
(11.1 |
) |
EBITDA |
$ |
47.1 |
|
|
$ |
45.1 |
|
|
|
|
|
||||
Transaction Adjustments |
|
|
|
||||
Equity-based compensation |
|
6.2 |
|
|
|
1.8 |
|
Straight-line rent adjustment |
|
0.4 |
|
|
|
0.6 |
|
Amortization of Favorable / Unfavorable Leasehold Interest & ARO accretion |
|
0.9 |
|
|
|
0.9 |
|
Stand-up separation & other |
|
1.5 |
|
|
|
0.4 |
|
Restructuring costs & other |
|
1.3 |
|
|
|
1.4 |
|
REIT conversion costs |
|
1.0 |
|
|
|
— |
|
Transaction-related costs |
|
— |
|
|
|
5.2 |
|
Change in fair value of warrant liabilities |
|
— |
|
|
|
2.7 |
|
Total Adjustments |
|
11.4 |
|
|
|
13.0 |
|
Transaction Adjusted EBITDA |
$ |
58.5 |
|
|
$ |
58.1 |
|
Note: Numbers may not foot or cross-foot due to rounding
RECONCILIATION OF GAAP TO NON-GAAP RESULTS (unaudited, in millions) |
|||||||
|
Nine Months Ended
|
||||||
|
2022 |
|
2021 |
||||
Net Loss to EBITDA Reconciliation: |
|
|
|
||||
Net loss |
$ |
(144.9 |
) |
|
|
(192.3 |
) |
Depreciation and amortization |
|
183.1 |
|
|
|
180.6 |
|
Interest and other expenses, net |
|
120.6 |
|
|
|
130.5 |
|
Income tax expense (benefit) |
|
1.6 |
|
|
|
(36.9 |
) |
EBITDA |
$ |
160.4 |
|
|
$ |
81.9 |
|
|
|
|
|
||||
Transaction Adjustments |
|
|
|
||||
Equity-based compensation |
|
16.0 |
|
|
|
5.4 |
|
Straight-line rent adjustment |
|
1.5 |
|
|
|
2.5 |
|
Amortization of Favorable / Unfavorable Leasehold Interest & ARO accretion |
|
2.7 |
|
|
|
2.6 |
|
Stand-up separation & other |
|
2.7 |
|
|
|
3.8 |
|
Restructuring costs & other |
|
3.9 |
|
|
|
72.3 |
|
REIT conversion costs |
|
1.7 |
|
|
|
— |
|
Transaction-related costs |
|
— |
|
|
|
5.2 |
|
Change in fair value of warrant liabilities |
|
(11.8 |
) |
|
|
2.7 |
|
Total Adjustments |
|
16.7 |
|
|
|
94.5 |
|
Transaction Adjusted EBITDA |
$ |
177.1 |
|
|
$ |
176.4 |
|
Note: Numbers may not foot or cross-foot due to rounding
View source version on businesswire.com: https://www.businesswire.com/news/home/20221108005383/en/
Press Contact:
press@cyxtera.com
Investor Relations Contact:
greer.aviv@cyxtera.com
Source:
FAQ
What were Cyxtera's financial results for Q3 2022?
How much did Cyxtera's recurring revenue increase in Q3 2022?
What is the significance of Cyxtera's positive net bookings?
What is Cyxtera's revenue guidance for full-year 2022?